PLC chooses Chindex for Heart Laser's Chinese expansion:
This article was originally published in Clinica
PLC Medical Systems has signed an exclusive distribution agreement with China Industrial Exchange (Chindex) to launch the Heart Laser System transmyocardial revascularisation (TMR) device in China. There are presently four systems in China and Hong Kong and PLC sees the expansion into China as a "vast new cardiac marketplace".
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.